×
Natera Inventory 2014-2025 | NTRA
Prices
Financials
Revenue & Profit
Assets & Liabilities
Margins
Price Ratios
Other Ratios
Other Metrics
Total Assets
Cash on Hand
Long Term Debt
Total Liabilities
Share Holder Equity
Natera inventory for the quarter ending March 31, 2025 was
$0.050B
, a
17.07% increase
year-over-year.
Natera inventory for 2024 was
$0.045B
, a
9.78% increase
from 2023.
Natera inventory for 2023 was
$0.041B
, a
15.12% increase
from 2022.
Natera inventory for 2022 was
$0.035B
, a
31.58% increase
from 2021.
View More
Natera Inventory 2014-2025 | NTRA
Prices
Financials
Revenue & Profit
Assets & Liabilities
Margins
Price Ratios
Other Ratios
Other Metrics
Total Assets
Cash on Hand
Long Term Debt
Total Liabilities
Share Holder Equity
Natera inventory for 2024 was
$0.045B
, a
9.78% increase
from 2023.
Natera inventory for 2023 was
$0.041B
, a
15.12% increase
from 2022.
Natera inventory for 2022 was
$0.035B
, a
31.58% increase
from 2021.
Related Stocks
Company Name
Market
Cap
Danaher (DHR)
$133.5B
Elevance Health (ELV)
$96.1B
CVS Health (CVS)
$84.8B
Cencora (COR)
$55.6B
DiDi Global (DIDIY)
$20.3B
BioMerieux (BMXMF)
$15.6B
Solventum (SOLV)
$11.5B
ICON (ICLR)
$11.3B
EUROFINS SCIENT (ERFSF)
$11.1B
Revvity (RVTY)
$11B
CochLear (CHEOY)
$10.9B
Avantor (AVTR)
$10.3B
Doximity (DOCS)
$9.9B
Viatris (VTRS)
$9B
Medpace Holdings (MEDP)
$9B
Sonic Healthcare (SKHHY)
$7.7B
HealthEquity (HQY)
$7.3B
Charles River Laboratories (CRL)
$5.2B
Amplifon S.p.A (AMFPF)
$4.3B
Bausch + Lomb (BLCO)
$4.3B
Alignment Healthcare (ALHC)
$3.5B
Sotera Health (SHC)
$3B
BrightSpring Health Services (BTSG)
$2.9B
Organon (OGN)
$2.9B
Surgery Partners (SGRY)
$2.7B
GeneDx Holdings (WGS)
$2.7B
Concentras Parent (CON)
$2.6B
Progyny (PGNY)
$1.8B
Ardent Health Partners (ARDT)
$1.8B
Premier (PINC)
$1.8B